Altoida Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 18

Altoida General Information

Description

Developer of a brain health assessment and neurocognitive test platform designed to detect Alzheimer's and dementia before their onset using augmented reality. The company's application tests the functional and cognitive aptitude of a patient via a machine-learning algorithm and offers a methodology based on longitudinal clinical studies, enabling doctors to detect Alzheimer's easily and help their patients to recover early.

Contact Information

Website
www.altoida.com
Formerly Known As
Alterniity
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 80 M Street South-East
  • Suite 100
  • Washington, DC 20003
  • United States
Corporate Office
  • 80 M Street South-East
  • Suite 100
  • Washington, DC 20003
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Altoida Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private Completed Generating Revenue
12. Later Stage VC (Series B) 01-Dec-2021 Cancelled Generating Revenue
11. Later Stage VC (Series A) 30-Mar-2022 Completed Generating Revenue
10. Accelerator/Incubator 09-Sep-2021 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
8. Later Stage VC (Series A) 17-May-2019 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
6. Seed Round 21-Dec-2016 Completed Generating Revenue
5. Grant $30.6M Completed Generating Revenue
4. Grant 27-Aug-2014 $22K Completed Generating Revenue
To view Altoida’s complete valuation and funding history, request access »

Altoida Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A 6,098,066 $0.000100 $0.09 $2.36 $2.36 1x $2.36 24.02%
Seed 1,911,761 $0.000100 $0.04 $1.07 $1.07 1x $1.07 7.53%
To view Altoida’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Altoida Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a brain health assessment and neurocognitive test platform designed to detect Alzheimer's and dementia befo
Decision/Risk Analysis
Washington, DC
29 As of 2026

Asheville, NC
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Altoida Competitors (29)

One of Altoida’s 29 competitors is NeuraMetrix, a Venture Capital-Backed company based in Asheville, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuraMetrix Venture Capital-Backed Asheville, NC
Linus Health Venture Capital-Backed Dublin, Ireland
CNS Vital Signs Corporation Morrisville, NC
Aural Analytics Formerly VC-backed Scottsdale, AZ
NantHealth Formerly VC-backed Lewisville, TX
You’re viewing 5 of 29 competitors. Get the full list »

Altoida Patents

Altoida Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230274835-A1 System and method for identifying prodromal parkinson's disease Pending 14-Feb-2022
EP-4430634-A1 System and method of analysing data for the determination of the condition of a person Pending 09-Nov-2021
US-20250006369-A1 System and method of analysing data for the determination of the condition of a person Pending 09-Nov-2021
WO-2023084363-A1 System and method of analysing data for the determination of the condition of a person Inactive 09-Nov-2021
JP-2024542414-A Systems and methods for analyzing data to assess a human medical condition - patents.com Pending 09-Nov-2021 G16H50/20
To view Altoida’s complete patent history, request access »

Altoida Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Altoida Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
b2venture Venture Capital Minority
Angel (individual) Minority
Eisai Corporate Venture Capital Minority
Eisai Innovation Corporate Venture Capital Minority
Hikma Ventures Corporate Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Altoida FAQs

  • When was Altoida founded?

    Altoida was founded in 2013.

  • Where is Altoida headquartered?

    Altoida is headquartered in Washington, DC.

  • What is the size of Altoida?

    Altoida has 29 total employees.

  • What industry is Altoida in?

    Altoida’s primary industry is Decision/Risk Analysis.

  • Is Altoida a private or public company?

    Altoida is a Private company.

  • What is Altoida’s current revenue?

    The current revenue for Altoida is .

  • How much funding has Altoida raised over time?

    Altoida has raised $21.3M.

  • Who are Altoida’s investors?

    b2venture, , Eisai, Eisai Innovation, and Hikma Ventures are 5 of 18 investors who have invested in Altoida.

  • Who are Altoida’s competitors?

    NeuraMetrix, Linus Health, CNS Vital Signs, Aural Analytics, and NantHealth are some of the 29 competitors of Altoida.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process